Medical gear maker Getinge beats Q3 profit estimates on pricing, product mix (updated)

Getinge publ AB

21/10/2026 08:56

Adds CEO quote from interview, share move in bullet points
Oct 21 (Reuters) - Swedish medical equipment maker Getinge GETIb.ST reported third-quarter core earnings above market expectations on Wednesday, helped by a favourable product mix and disciplined pricing.    
    The maker of products for surgery, intensive care and sterilisation has spent the past year countering pressure from higher US import tariffs by raising prices, cutting costs and adjusting its supply chain.
Getinge's adjusted EBITA rose 18% to 1.28 billion Swedish crowns ($129 million) in the quarter. Analysts were expecting 1.19 billion crowns on average, a company-provided poll showed.  
The group, which manufactures more than 60% of its products in the US, said its third-quarter adjusted EBITA margin benefited from 45 million crowns in tariff refunds and about 36 million crowns from year-on-year currency effects.
"In the quarter, we actually had higher tariff costs than refunds," CEO Mattias Perjos told Reuters, adding that Getinge had received a full refund of tariffs paid under IEEPA but was now paying new tariffs, mainly the 10% levy on EU goods entering the United States.
Getinge's quarterly orders rose 2.6% organically, marking an eleventh straight quarter of growth, driven by its Acute Care Therapies and Surgical Workflows units.
The company, whose products include ventilators and equipment for operating rooms, confirmed its forecast of organic sales growth of 3% to 5% for 2026, compared with 4.9% last year. 
Shares were up 1.9% as of 0750 GMT.


($1 = 9.9102 Swedish crowns)

 (Reporting by Marta Frackowiak; Editing by Bartosz Dabrowski)
 ((marta.frackowiak@thomsonreuters.com))